Abstract:e14580 Background: Human Granzymes (GZMs) are mainly regarded as protective cytotoxic proteases that block the development of cancer. This study aimed to systematically analyze the expression signature, immune infiltration pattern, predictive values of prognosis and immune response, and the biological process associated with GZMs in different cancers. Methods: We estimated the predictive values of GZMs in prognosis and drug sensitivities by Cox regression analysis, immunophenoscore (IPS) algorithm, etc. We identified potential factors associated with the expression of GZMs, involving the somatic mutation and copy number variation of driver genes. We further investigate the distributions of GZMs and their discrepancy in single-cell resolution. The package CellChat and SCENIC were used for cell-cell communications and regulatory network reconstruction respectively. The ssGSEA algorithm was used to calculate the GZMs score for a gene set of five granzymes and the enrichment score (ES) of regulons based on the bulk-seq data. We chose the specific regulons to cluster patients in pan-cancer. Results: In the immunotherapy context, the higher GZMs score was associated with better overall survival (OS) in urothelial carcinoma (HR = 0.31, p< 0.01). In melanoma, the pooled HR value calculated by meta-analysis assay was 0.33 (95%CI: 0.189-0.58). In the single-cell resolution, we found the three patterns of GZMs expression in CD8+T/NK cells. Furthermore, we analyzed the discrepancy among different GZMs subtype cells in functions, cell-cell communications, and cell-type-specific regulons. In CD8+ Effector memory T cells, cluster 1 (GZMB+) and cluster 2 (GZMK+) exhibited different enriched pathways in adhesion, anti-bacteria, chemotaxis, migration, and metabolism. In the cell-cell communications analysis, the IFNG − (IFNGR1+IFNGR2) between CD8+ T cells and malignant cells was only significant in the C1 and C2 clusters. Pan-cancer patients were divided into five regulons clusters based on the regulons. Cluster 5 had the worst OS (HR = 8.49, 95%CI = 6.67-10.81, p< 0.01) compared to cluster 1 which had the best prognosis. Cluster 5 had higher ES of regulons including Myb, Hmgb2, E2f7, E2f8, and lower ES of Egr3. Conclusions: In conclusion, the expressions of GZMs, GZMs score, and the specific regulons identified in this study were associated with the prognosis in pan-cancer patients. GZMs score was a valuable biomarker that can predict the response to immunotherapy. The patients who belong to different regulons subtypes have specific transcription factors, which may be potential targets for the precision medicine of anti-tumor strategies in pan-cancer.

Granzyme mRNA-miRNA interaction and its implication to functional impact

A Pan-Cancer Analysis of the Granzyme Family Based on the TCGA Database and Single-Cell RNA Sequencing Data.

Distinct granzyme k expression in immune cells: a single-cell rna-seq meta-analysis

Granzymes in health and diseases: the good, the bad and the ugly

Dysregulation of the Mitogen Granulin in Human Cancer Through the Mir-15/107 Microrna Gene Group.

Interaction Networks Converging on Immunosuppressive Roles of Granzyme B: Special Niches Within the Tumor Microenvironment

Granzymes Expression Patterns Predict Immunotherapy Response and Identify the Heterogeneity of CD8 T Cell Subsets

Elevated levels of granzyme B correlated with miR-874-3p downregulation in patients with acute myocardial infarction.

Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell–Mediated Cytotoxicity

Identification of Resting and Type I Ifn-Activated Human Nk Cell Mirnomes Reveals Microrna-378 and Microrna-30e As Negative Regulators of Nk Cell Cytotoxicity

Comparison in the Effects of IL‐2, IL‐12, IL‐15 and IFN[alpha] on Gene Regulation of Granzymes of Human NK Cell Line NK‐92

Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis

Granzyme B Promotes Proliferation, Migration and EMT Process in Gastric Cancer

Granzyme family acts as a predict biomarker in cutaneous melanoma and indicates more benefit from anti-PD-1 immunotherapy

MicroRNAs and Apoptosis: Implications in the Molecular Therapy of Human Disease

Abstract LB-352: Functional Significance of Zic1 and Hsa-Mir-23a Over-Expression in Malignant Mesothelioma

Granzyme serine proteases in inflammation and rheumatic diseases

Exploring GZMK as a prognostic marker and predictor of immunotherapy response in breast cancer: unveiling novel insights into treatment outcomes

Clinical Significance of Granzyme B Gene Expression in Pathological Stage II/III Gastric Cancer After Curative Gastrectomy

Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentials

Ectopic Expression of Active Granzyme B Gene Leads to Multinuclear Giant Cels